To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
NIH Extends Agreement with Galapagos
Galapagos NV announced that the U.S. National Institutes of Health (NIH) have extended their agreement with Galapagos' service division BioFocus DPI for the operation of the Molecular Libraries Small Molecule Repository (MLSMR) until December 2010.
According to the terms of this agreement, Galapagos will receive more than $9 million (€5.7 million) over the course of the two year extension.
BioFocus DPI runs a compound management facility for a number of industrial and U.S. government customers out of its Compound Focus, Inc. subsidiary in South San Francisco.
Home to the MLSMR since 2004, this facility acquires and stores compounds under the contract with NIH and distributes these compounds for high-throughput biological screening throughout the NIH's academic network in the U.S.
"We are pleased that the NIH has elected to continue working with BioFocus DPI. Through this extended agreement, the compound management facility has once again demonstrated that it is a leading provider of these services," said Onno van de Stolpe, CEO of Galapagos.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
